Top Markets
#1 GALA GALA +31.36%
#2 Fabric Protocol Fabric Protocol +30.87%
#3 Bitcoin Cash Bitcoin Cash +30.67%
#4 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +30.64%
#5 Tutorial Tutorial +30.38%
#6 GoPlus Security GoPlus Security +25.74%
#7 Zora Zora +24.48%
#8 Talus Network Talus Network +24.40%
#9 aPriori aPriori +23.76%
#10 Kamino Kamino +23.25%
Coin of the day
GALA GALA
Settings
Language
ENGLISH
Currency
USD
Theme
Miromatrix Medical Inc. Miromatrix Medical Inc.

Miromatrix Medical Inc.

MIRO
Rank in Stocks #24471
Miromatrix Medical Inc. is a life sciences company dedicated to pioneering a... Miromatrix Medical Inc. is a life sciences company dedicated to pioneering a novel technology for bioengineering organs that are fully transplantable. Central to its innovative work is a proprietary platform utilizing a two-stage method involving decellularization and recellularization. This sophisticated process entails meticulously removing the native porcine cells from organs harvested from pigs, then introducing unmodified human cells to create viable new structures. Miromatrix maintains significant partnerships with esteemed medical institutions such as The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company, which was originally incorporated in 2009 under the name TayTech, Inc., operates from its headquarters in Eden Prairie, Minnesota.
Share Price
$3.39
Last synced: 2023-12-22
Market Cap
$60.24M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Miromatrix Medical Inc. (MIRO)

Category

Healthcare
Revenue for Miromatrix Medical Inc. (MIRO)
Revenue in Aug 2026 TTM: 0
According to Miromatrix Medical Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Miromatrix Medical Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH